CASTRATE SENSITIVE PROSTATE CANCER
Clinical trials for CASTRATE SENSITIVE PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATE SENSITIVE PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATE SENSITIVE PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to halt spread of prostate cancer
Disease control OngoingThis study tests a new treatment for men with prostate cancer that has spread to a few other places in the body. The treatment combines targeted radiation with hormone therapy and a drug called olaparib. The goal is to see if this approach can stop the cancer from growing for at …
Matched conditions: CASTRATE SENSITIVE PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New combo therapy and advanced scans aim to better detect and treat prostate cancer
Disease control OngoingThis study tests a combination of three hormone-blocking drugs (enzalutamide, abiraterone, and standard hormone therapy) in men with newly diagnosed prostate cancer that hasn't spread. Researchers also use advanced PET/CT scans with a special tracer to see if they can better dete…
Matched conditions: CASTRATE SENSITIVE PROSTATE CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC